[长效复合人间白血素-2药物的生物活性和抗瘤作用]
Xuejun Liang1, Fengxia Zhang1, Ting Jin1
1Novocodex Biopharmaceuticals Company Limited, Shaoxing 312000, Zhejiang, China.
概括
佩吉化复合人间白蛋白2 (PEG-rhIL-2) 通过增加CD8+T细胞显示出显著的抗瘤作用. 这种修改后的生物体在癌症治疗中表现有前途,增强了对瘤的免疫反应.
科学领域:
- 生物技术和免疫学 生物技术和免疫学
- 癌症生物学和治疗方法
- 蛋白质工程和药物开发.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.7K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
510
相关概念视频
01:27Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K